Development Begins On Final Phase Of $100 Million Construction Project At BioTechnology Research Park In Richmond, Virginia
04/23/2013
This facility is an expansion for Health Diagnostic Laboratories, Inc., a CLIA-certified and CAP-accredited laboratory, health management and bioscience company, offering a comprehensive test menu of risk factors and biomarkers for cardiovascular disease, diabetes and related diseases.
The Phase III BioTech 8 expansion for HDL will take total development at the Virginia BioTechnology Research Park to more than 1.25 million sq. ft. HDL's growth combined with the BioTech Park's unique mix of over 60 public and private bioscience companies, including three publicly traded firms, contribute to this park's success in attracting companies globally.
The Lingerfelt Companies Principal Ryan Lingerfelt said, "Since partnering with HDL in 2009, development has been fast paced with the third phase six-story tower scheduled for completion spring 2014. Lingerfelt is pleased to assist HDL in their expansion by developing all three of their buildings within the BioTechnology Research Park totaling 276,000 sq. ft. and a $100 million investment. HDL is a significant complement to our growing health care development portfolio. We have enjoyed partnering with such a high-quality and successful company."
Project Announcements
Novartis Gene Therapies Plans Denton, Texas, Operations
03/04/2026
Berwick Industries Expands Columbia County, Pennsylvania, Operations
03/03/2026
Akston Establishes Caddo Parish, Louisiana, Manufacturing Operations
03/02/2026
US Forged Rings Plans Hertford County, North Carolina, Steel Component Operations
03/02/2026
South Korea-Based Hanjung America Plans Huntington, Indiana, Manufacturing Operations
03/02/2026
Faith Technologies Plans Opelika, Alabama, Manufacturing Operations
03/01/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
Strategic Industries at the Crossroads: Defense, Aerospace, and Maritime Enter 2026
Q1 2026